Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for InvestorsZacks Investment Research • 11/12/25
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to TradeZacks Investment Research • 11/11/25
ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv SalesZacks Investment Research • 11/06/25
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 11/05/25
ADMA Biologics Inc (ADMA) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 10/30/25
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025GlobeNewsWire • 10/29/25
Adma Biologics (ADMA) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 09/25/25
ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG PlatformSeeking Alpha • 08/10/25
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 08/06/25
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025GlobeNewsWire • 07/30/25
Adma Biologics (ADMA) Outperforms Broader Market: What You Need to KnowZacks Investment Research • 07/09/25
ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade)Seeking Alpha • 06/15/25